We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alizyme | LSE:AZM | London | Ordinary Share | GB0000374289 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.08 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAZM RNS Number : 4135R Alizyme PLC 30 April 2009 +---------------------------------------+---------------------------------------+ | FOR IMMEDIATE RELEASE | 30 APRIL 2009 | +---------------------------------------+---------------------------------------+ ALIZYME PLC 2008 ANNUAL REPORT AND ACCOUNTS Cambridge UK, 30 April 2009: Alizyme plc (LSE: AZM) gives notice that copies of the 2008 Annual Report and Accounts have been sent to shareholders. These documents are available on the Investor Relations - Financial Reports page of the Company's web site at 'www.alizyme.com'. Copies of these documents have been submitted to the UK Listing Authority for publication through the UK Listing Authority's Document Viewing Facility, which is situated at The Financial Services Authority, 25 The North Colonnade, Canary Wharf, London, E14 5HS (UKLA telephone helpline: +44 (0) 20 7066 8333), and will shortly be available for viewing. Further copies of the 2008 Annual Report and Accounts are available from the Company Secretary, Alizyme plc, Granta Park, Great Abington, Cambridge, CB21 6GX (telephone number: +44 (0) 1223 896000). Alizyme plc also announces that its Annual General Meeting ("AGM") will be held on Friday, 24 July 2009. The meeting will be held at the offices of Buchanan Communications, 45 Moorfields, London, EC2Y 9AE, commencing at 11.00 a.m. The Notice of the Annual General Meeting will be sent to shareholders in due course. - Ends - For further information, please contact: +---------------------------------------+---------------------------------------+ | ALIZYME plc | Tel No: + 44 (0) 1223 896000 | | Tim McCarthy, Chief Executive Officer | | | | | +---------------------------------------+---------------------------------------+ Further information on Alizyme can be found on the Company's website: www.alizyme.com This information is provided by RNS The company news service from the London Stock Exchange END ACSCKCKNABKDNQB
1 Year Alizyme Chart |
1 Month Alizyme Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions